Browsing by Titles
Showing results 1 to 6 of 6
- ;
- ;
- ;
- ;
- ;
- ;
- Choe, Han Kyoung ;
- ;
- Hille, Bertil ;
- Suh, Byung-Chang
- 2025-01
- Kim, Jung-Eun. (2025-01). Activation of TMEM16E scramblase induces ligand independent growth factor receptor signaling and macropinocytosis for membrane repair. Communications Biology, 8(1). doi: 10.1038/s42003-025-07465-6
- Nature Publishing Group
- View : 412
- Download : 49
- Le, Phuong ;
- Lim, Sung Jun ;
- Baculis, Brian C. ;
- Chung, Hee Jung ;
- Kilian, Kristopher A. ;
- Smith, Andrew M.
- 2019-02
- Le, Phuong. (2019-02). Counting growth factors in single cells with infrared quantum dots to measure discrete stimulation distributions. Nature Communications, 10(1). doi: 10.1038/s41467-019-08754-5
- Nature Publishing Group
- View : 1003
- Download : 146
- Choi, Hee-Jeong ;
- ;
- Kim, Jieun ;
- 2023-08
- Choi, Hee-Jeong. (2023-08). EGFR is a potential dual molecular target for cancer and Alzheimer’s disease. Frontiers in Pharmacology, 14. doi: 10.3389/fphar.2023.1238639
- Frontiers
- View : 209
- Download : 23
Article
Erlotinib regulates short-term memory, tau/Aβ pathology, and astrogliosis in mouse models of AD
- Lee, Hyun-Ju ;
- Hwang, Jeong-Woo ;
- Kim, Jieun ;
- Jo, A-Ran ;
- Park, Jin-Hee ;
- ;
- ;
- Kim, Su-Jeong ;
- Song, Jeong-Heon ;
- 2024-10
- Lee, Hyun-Ju. (2024-10). Erlotinib regulates short-term memory, tau/Aβ pathology, and astrogliosis in mouse models of AD. Frontiers in Immunology, 15. doi: 10.3389/fimmu.2024.1421455
- Frontiers Media
- View : 223
- Download : 24
- Kiwook Kim
- 2023
- Kiwook Kim. (2023). Inferring Kinetic Model for Regulating EGFR Dimerization via the Single-Molecule and the Ensemble Assay. doi: 10.22677/THESIS.200000656334
- DGIST
- View : 195
- Download : 0
- Kim, Nayoung ;
- Cho, Ahye ;
- Watanabe, Hideo ;
- Choi, Yoon-La ;
- Aziz, Meraj ;
- Kassner, Michelle ;
- Joung, Je-Gun ;
- Park, Angela K. J. ;
- Francis, Joshua M. ;
- Bae, Joon Seol ; et al
- 2016-03
- Kim, Nayoung. (2016-03). Integrated genomic approaches identify upregulation of SCRN1 as a novel mechanism associated with acquired resistance to erlotinib in PC9 cells harboring oncogenic EGFR mutation. Oncotarget, 7(12), 13797–13809. doi: 10.18632/oncotarget.7318
- Impact Journals LLC
- View : 1024
- Download : 0
1
